The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...

Oncology testing segment is projected to register highest growth rate in the chemiluminescence immunoassay market, by application, during the forecast period The global chemiluminescence ...

Which MedTech key players in the Chemiluminescence Immunoassay market are set to emerge as the trendsetter, explore @ Chemiluminescence Immunoassay Companies Table of Contents 1.

SNS Insider Unveils Strategic Insights into the U.S. Chemiluminescence Immunoassay Market's Growth Trajectory-Valued at USD 3.66 Billion in 2023-Powe ...

CHICAGO, July 5, 2023 /PRNewswire/ -- In the near future, the chemiluminescence immunoassay industry is set to witness remarkable advancements, revolutionizing diagnostics and research in various ...

Chemiluminescent Enzyme Immunoassay (CLEIA) represents a breakthrough in diagnostics, combining the unparalleled sensitivity of chemiluminescence and distinctive specificity.

The global market for Chemiluminescence Immunoassay Analyzers was valued at US$6.5 Billion in 2024 and is projected to reach US$10.7 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030. This ...

NEW YORK, Nov. 28, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global immunoassay market size is estimated to grow by USD 8.64 billion from 2024-2028, according to ...

Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the “Company” or “Anbio”), a global diagnostic company dedicated to the advancement of medical technology ...

According to SNS Insider, the Chemiluminescence Immunoassay (CLIA) Market was valued at USD 11.76 billion in 2023 and is projected to reach USD 17.72 billion by 2032, growing at a CAGR of 4.68% during ...